Literature DB >> 7879704

Immune-related edemagenic activity of glutamines and glutamic acid, components of immunomodulatory agents.

Z Zídek1.   

Abstract

A number of compounds, in their structure similar to the immunomodulatory agent adamantylamide-L-alanyl-D-isoglutamine (AdDP), a desmuramyl analog of muramyl dipeptide (MDP), were compared with respect to their in vivo immunobiological activity. The agents were represented by adamantylamide-peptides or -amino acids differing principally in the nature of glutaminyl moieties. They were all able to induce inflammatory reaction which was prevented by anti-T-cell (TH) mAb, silica, indomethacin and dexamethasone. Responsible for this effect proved to be glutaminyl moieties (glutamine, isoglutamine, or glutamic acid), irrespective of their stereospecificity. Unlike the immunomodulatory molecule of AdDP, neither of the compounds and amino acids were able to stimulate production of antibodies in immunized animals, however.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7879704     DOI: 10.1007/bf01983485

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  14 in total

1.  Modulation of lymphocyte proliferation by enzymes that degrade amino acids.

Authors:  J C Chuang; C L Yu; S R Wang
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

2.  Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells.

Authors:  P J Knudsen; C A Dinarello; T B Strom
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

3.  Alterations in the immune system in cats fed diets with excess cystine.

Authors:  G B Schuller-Levis; R Recce; R D Rudelli; J Sturman
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

4.  Further improvements in the plaque technique for detecting single antibody-forming cells.

Authors:  A J Cunningham; A Szenberg
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

5.  Effect of dexamethasone on mechanisms responsible for regulation of polyclonal B-cell response.

Authors:  J Pryjma; H D Flad; B Mytar; J Ennen; M Ernst
Journal:  Int J Immunopharmacol       Date:  1989

6.  Structure specificity of some immunoadjuvant synthetic glycopeptides.

Authors:  K Masek; M Zaoral; J Jezek; V Krchnák
Journal:  Experientia       Date:  1979-10-15

7.  Comparison of immunomodulatory activities in mice and guinea pigs of a synthetic desmuramyl peptidolipid triglymyc.

Authors:  C D Leclerc; F M Audibert; L A Chedid; E J Deriaud; N K Masihi; E Lederer
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

8.  Some cellular and pathophysiological correlates of the inflammatory effects of a synthetic immunomodulatory agent, muramyl dipeptide (MDP).

Authors:  Z Zídek; D Franková; K Masek
Journal:  Agents Actions       Date:  1993-01

9.  T-cell-dependent immunobiological activity of a desmuramyl analog of muramyl dipeptide, adamantylamide dipeptide (AdDP), and D-isoglutamine.

Authors:  Z Zídek; K Masek; D Franková; M Flegel
Journal:  Int J Immunopharmacol       Date:  1993-07

10.  Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA.

Authors:  S W Lee; A P Tsou; H Chan; J Thomas; K Petrie; E M Eugui; A C Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

View more
  2 in total

1.  Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).

Authors:  Marlyn P Langford; Dequan Chen; Tomas C Welbourne; Thomas B Redens; James P Ganley
Journal:  Mol Cell Biochem       Date:  2002-07       Impact factor: 3.396

2.  Immune modulator adamantylamide dipeptide stimulates efficient major histocompatibility complex class I-restricted responses in mice.

Authors:  Pablo D Becker; Miriam Nörder; Carlos A Guzmán; Saul Grinstein
Journal:  Clin Vaccine Immunol       Date:  2007-03-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.